Related Experiment Video
Updated: May 20, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
Apico-aortic conduit for severe hypertrophic cardiomyopathy: sudden death despite conduit patency 31 years
Gianantonio Nappi1, Giovanni Dialetto, Marisa De Feo
1Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, c/o V. Monaldi Hospital, via L Bianchi, Naples, Italy.
Insights
Apico-aortic valved conduit offers long-term symptom relief for select hypertrophic cardiomyopathy (HCM) patients when myectomy is not feasible. However, it does not prevent late-stage disease progression.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Case Study
Background:
- Hypertrophic cardiomyopathy (HCM) presents challenges in treatment, particularly when severe ventricular hypertrophy obstructs the outflow tract.
- Conventional myectomy may not be suitable for all HCM patients, necessitating alternative surgical approaches.
Observation:
- A young female patient with severe, diffuse HCM underwent apico-aortic valved conduit surgery due to an absent outflow tract cavity.
- Long-term follow-up over 31 years revealed sustained symptom relief and successful pregnancies.
- Imaging confirmed excellent conduit patency without bioprosthetic calcification.
Findings:
- The apico-aortic conduit provided 30 years of symptom-free living without medication.
- Despite surgical success, the patient's HCM progressed to a dilative phase.
- Sudden death occurred while awaiting advanced heart failure management.
Implications:
- Apico-aortic valved conduit may be a viable option for carefully selected HCM patients unsuitable for myectomy.
- While effective for obstruction relief, this approach does not preclude the eventual development of end-stage heart failure.
- This case highlights the potential for durable palliation but underscores the progressive nature of HCM.
Abstract:
Although small experiences have been described with the use of apico-aortic valved conduit in the treatment of hypertrophic cardiomyopathy (HCM), the long-term follow-up has never been previously reported. In a young female patient with symptomatic HCM and a prognostically unfavorable phenotype, apico-aortic conduit was chosen instead of conventional myectomy because severe ventricular hypertrophy involved the whole ventricle, making outflow tract cavity virtually absent in systole. Close clinical and imaging follow-up was postoperatively performed. The patient remained asymptomatic, without cardioactive drug therapy for 30 years, also experiencing 2 successful pregnancies. A striking finding was the perfect patency of the conduit at the last follow-up control (31 years), with computed tomography and echocardiography showing no calcification of the porcine Hancock bioprosthesis inside the graft. Nevertheless, the disease slowly evolved towards the dilative phase and the patient experienced sudden death while scheduled for implantation of defibrillator in waiting list for heart transplant.The present case could suggest that, in selected cases of HCM not treatable by myectomy, apico-aortic conduit may be an option. The relief of the obstruction can provide even long-term freedom from symptoms, however, late evolution to end-stage cannot be prevented.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

